Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02073994
Title	Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Institut de Recherches Internationales Servier
Indications	Advanced Solid Tumor
Therapies	Ivosidenib
Age Groups:	senior \| adult
Covered Countries	USA \| FRA